Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn’s Disease Patients Treated with High-Dose Vitamin D Alone or Combined with Infliximab

Background: Vitamin D treatment may reduce Crohn’s disease (CD) activity by modulating the mucosal immune function. We investigated if high-dose vitamin D +/− infliximab modulated the mucosal cytokine expression in active CD. Methods: Forty CD patients were randomized into: infliximab + vitamin D; i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bendix, Mia, Dige, Anders, Jørgensen, Søren Peter, Dahlerup, Jens Frederik, Bibby, Bo Martin, Deleuran, Bent, Agnholt, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759913/
https://www.ncbi.nlm.nih.gov/pubmed/33266022
http://dx.doi.org/10.3390/nu12123699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759913/
https://www.ncbi.nlm.nih.gov/pubmed/33266022
http://dx.doi.org/10.3390/nu12123699

Ejemplares similares